The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy

T. D. LeVan, S. Guerra, W. Klimecki, M. M. Vasquez, I. C. Lohman, F. D. Martinez, M. Halonen, A. L. Wright

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

CD14 is a receptor involved in the recognition of lipopolysaccharide and other bacterial wall components that may be involved in the balance between infectious and allergic disease and the early polarization towards TH1. Our group has shown an association between polymorphisms in the 5′ flanking region of the CD14 gene and plasma soluble CD14 (sCD14) levels at 11 years of age. However, whether this association is present at birth and in infancy remains to be determined. In this study, we measured sCD14 levels in plasma from the umbilical cord (n = 387) and at 3 months (n = 357) and 1 year (n=312) of age in non-selected healthy infants to assess their relationship with CD14 genotypes at -4190, -2838, -1720 and -260 (relative to translation start site). There was no relation of CD14 genotypes with sCD14 at birth. However, there was a significant association between CD14 genotypes and sCD14 as early as 3 months. Longitudinal analysis suggests that CD14 polymorphisms modulate sCD14 levels up to 1 year of age. This association early in life may have an impact on TH1 polarization and subsequent protection against allergic disease.

Original languageEnglish (US)
Pages (from-to)77-80
Number of pages4
JournalGenes and Immunity
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Genotype
Parturition
Umbilical Cord
5' Flanking Region
Communicable Diseases
Lipopolysaccharides
Genes

Keywords

  • Allergy
  • Atopy
  • CD14
  • Infancy
  • Innate immunity
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Immunology
  • Genetics
  • Genetics(clinical)

Cite this

LeVan, T. D., Guerra, S., Klimecki, W., Vasquez, M. M., Lohman, I. C., Martinez, F. D., ... Wright, A. L. (2006). The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. Genes and Immunity, 7(1), 77-80. https://doi.org/10.1038/sj.gene.6364276

The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. / LeVan, T. D.; Guerra, S.; Klimecki, W.; Vasquez, M. M.; Lohman, I. C.; Martinez, F. D.; Halonen, M.; Wright, A. L.

In: Genes and Immunity, Vol. 7, No. 1, 01.01.2006, p. 77-80.

Research output: Contribution to journalArticle

LeVan, TD, Guerra, S, Klimecki, W, Vasquez, MM, Lohman, IC, Martinez, FD, Halonen, M & Wright, AL 2006, 'The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy', Genes and Immunity, vol. 7, no. 1, pp. 77-80. https://doi.org/10.1038/sj.gene.6364276
LeVan, T. D. ; Guerra, S. ; Klimecki, W. ; Vasquez, M. M. ; Lohman, I. C. ; Martinez, F. D. ; Halonen, M. ; Wright, A. L. / The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. In: Genes and Immunity. 2006 ; Vol. 7, No. 1. pp. 77-80.
@article{80fecb438494460f96c95ba674e9f5ad,
title = "The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy",
abstract = "CD14 is a receptor involved in the recognition of lipopolysaccharide and other bacterial wall components that may be involved in the balance between infectious and allergic disease and the early polarization towards TH1. Our group has shown an association between polymorphisms in the 5′ flanking region of the CD14 gene and plasma soluble CD14 (sCD14) levels at 11 years of age. However, whether this association is present at birth and in infancy remains to be determined. In this study, we measured sCD14 levels in plasma from the umbilical cord (n = 387) and at 3 months (n = 357) and 1 year (n=312) of age in non-selected healthy infants to assess their relationship with CD14 genotypes at -4190, -2838, -1720 and -260 (relative to translation start site). There was no relation of CD14 genotypes with sCD14 at birth. However, there was a significant association between CD14 genotypes and sCD14 as early as 3 months. Longitudinal analysis suggests that CD14 polymorphisms modulate sCD14 levels up to 1 year of age. This association early in life may have an impact on TH1 polarization and subsequent protection against allergic disease.",
keywords = "Allergy, Atopy, CD14, Infancy, Innate immunity, Single nucleotide polymorphism",
author = "LeVan, {T. D.} and S. Guerra and W. Klimecki and Vasquez, {M. M.} and Lohman, {I. C.} and Martinez, {F. D.} and M. Halonen and Wright, {A. L.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1038/sj.gene.6364276",
language = "English (US)",
volume = "7",
pages = "77--80",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy

AU - LeVan, T. D.

AU - Guerra, S.

AU - Klimecki, W.

AU - Vasquez, M. M.

AU - Lohman, I. C.

AU - Martinez, F. D.

AU - Halonen, M.

AU - Wright, A. L.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - CD14 is a receptor involved in the recognition of lipopolysaccharide and other bacterial wall components that may be involved in the balance between infectious and allergic disease and the early polarization towards TH1. Our group has shown an association between polymorphisms in the 5′ flanking region of the CD14 gene and plasma soluble CD14 (sCD14) levels at 11 years of age. However, whether this association is present at birth and in infancy remains to be determined. In this study, we measured sCD14 levels in plasma from the umbilical cord (n = 387) and at 3 months (n = 357) and 1 year (n=312) of age in non-selected healthy infants to assess their relationship with CD14 genotypes at -4190, -2838, -1720 and -260 (relative to translation start site). There was no relation of CD14 genotypes with sCD14 at birth. However, there was a significant association between CD14 genotypes and sCD14 as early as 3 months. Longitudinal analysis suggests that CD14 polymorphisms modulate sCD14 levels up to 1 year of age. This association early in life may have an impact on TH1 polarization and subsequent protection against allergic disease.

AB - CD14 is a receptor involved in the recognition of lipopolysaccharide and other bacterial wall components that may be involved in the balance between infectious and allergic disease and the early polarization towards TH1. Our group has shown an association between polymorphisms in the 5′ flanking region of the CD14 gene and plasma soluble CD14 (sCD14) levels at 11 years of age. However, whether this association is present at birth and in infancy remains to be determined. In this study, we measured sCD14 levels in plasma from the umbilical cord (n = 387) and at 3 months (n = 357) and 1 year (n=312) of age in non-selected healthy infants to assess their relationship with CD14 genotypes at -4190, -2838, -1720 and -260 (relative to translation start site). There was no relation of CD14 genotypes with sCD14 at birth. However, there was a significant association between CD14 genotypes and sCD14 as early as 3 months. Longitudinal analysis suggests that CD14 polymorphisms modulate sCD14 levels up to 1 year of age. This association early in life may have an impact on TH1 polarization and subsequent protection against allergic disease.

KW - Allergy

KW - Atopy

KW - CD14

KW - Infancy

KW - Innate immunity

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=33645142444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645142444&partnerID=8YFLogxK

U2 - 10.1038/sj.gene.6364276

DO - 10.1038/sj.gene.6364276

M3 - Article

C2 - 16395394

AN - SCOPUS:33645142444

VL - 7

SP - 77

EP - 80

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 1

ER -